Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 4/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.58 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.58 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.58 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | PNP | P00491 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7065756 | 1.00 | TYMP (0.71) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL1774838 | 0.93 | TYMP (0.63) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL29529385 | 0.93 | TYMP (0.63) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL7871248 | 0.93 | TYMP (0.63) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL1774839 | 0.93 | TYMP (0.63) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL29574745 | 0.93 | TYMP (0.63) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL6910499 | 0.87 | TYMP (0.57) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL18817976 | 0.87 | TYMP (0.58) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL10430363 | 0.86 | TYMP (0.54) | TYMPPOLBADORA1ENPP1P2RY1 | |
| SCHEMBL22367653 | 0.85 | TYMP (0.65) | TYMPPOLBENPP1P2RY1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | AJINOMOTO CO., INC (JP) | 2003-10-30 | — | — | US | disclosed |
| US-6579976-B2 | Producing compounds having sugar-moiety hydroxyl groups or halogen atoms reduced in nucleic acids by allowing O-thiocarbonyl derivatives or halogenated derivatives in the sugar-moiety react with hypophosphorous acids or salts | AJINOMOTO CO., INC. (JP) | 2003-06-17 | — | — | US | disclosed |
| US-20020045744-A1 | PROCESS FOR PRODUCING NUCLEIC ACID DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-0999218-A1 | Process for producing nucleoside derivatives | Ajinomoto Co., Inc. (JP) | 2000-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | RNGTT, DOHH, NT5C3B | TYMP 38/4885POLB 183/4885ADORA1 2863/4885 |
| US-20020045744-A1 | PROCESS FOR PRODUCING NUCLEIC ACID DERIVATIVES | RNGTT, OSGEP, PNP | TYMP 19/4885POLB 77/4885ADORA1 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.